Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
Dermatology
•
Primary Care
Do you adjust PSA for finasteride use when determining prostate cancer stage and risk category?
If this upstages the patient, do you modify treatment recommendations?
Answer from: Radiation Oncologist at Community Practice
We generally use the rule of 50% (real PSA is twice the lab value when on Finasteride).
Sign In
or
Register
to read more
7534
Related Questions
Do you utilize daily enemas for patients undergoing prostate SBRT?
How do you follow/manage patients with metastatic prostate cancer with undetectable PSA and castration-sensitive but active disease on PSMA PET?
What are your institution's standard liquid intake instructions for prostate cancer patients going through definitive external beam radiation?
How would you manage a patient who developed an intraprostatic abscess after SpaceOAR injection, prior to starting radiation?
How do you manage PSA progression while a patient is on Xofigo or Pluvicto?
In light of the recent data indicating increased late grade 3 to 5 toxicities (LTOX3) after hypofractionated salvage radiation therapy, will you continue to offer these regimes to patients?
Should a patient who requires definitive treatment for prostate cancer as a pre-transplant requirement be strictly required to complete their course prior to transplant/initiation of immunosuppression?
How can you manage a patient with bilateral PCNs who requires Pluvicto administration?
How do you approach ADT in patients with high-risk prostate cancer who have risk factors for VTE, such as Factor V Leiden?
What are your top takeaways from ASCO GU 2025?